Osteoarthritis Pain Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL OSTEOARTHRITIS PAIN DRUGS INDUSTRY

2.1 Summary about Osteoarthritis Pain Drugs Industry

2.2 Osteoarthritis Pain Drugs Market Trends

2.2.1 Osteoarthritis Pain Drugs Production & Consumption Trends

2.2.2 Osteoarthritis Pain Drugs Demand Structure Trends

2.3 Osteoarthritis Pain Drugs Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Oral

4.2.2 Injection

4.2.3 External

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Hospitals

4.3.2 Clinics

4.3.3 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Oral

5.2.2 Injection

5.2.3 External

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Hospitals

5.3.2 Clinics

5.3.3 Others

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Oral

6.2.2 Injection

6.2.3 External

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Hospitals

6.3.2 Clinics

6.3.3 Others

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Oral

7.2.2 Injection

7.2.3 External

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Hospitals

7.3.2 Clinics

7.3.3 Others

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Oral

8.2.2 Injection

8.2.3 External

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Hospitals

8.3.2 Clinics

8.3.3 Others

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Oral

9.2.2 Injection

9.2.3 External

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Hospitals

9.3.2 Clinics

9.3.3 Others

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Abbott Laboratories

10.1.2 Johnson & Johnson

10.1.3 Novartis International

10.1.4 Pfizer

10.1.5 Abiogen Pharma

10.1.6 Afferent Pharmaceuticals

10.1.7 Astellas Pharma

10.1.8 BioDelivery Sciences International

10.1.9 Crystal Genomics

10.1.10 Cytori Therapeutics

10.1.11 Daiichi Sankyo

10.1.12 Eli Lilly

10.1.13 Endo Pharmaceuticals Holdings

10.1.14 Horizon Pharma

10.1.15 ICeutica

10.1.16 Iroko Pharmaceuticals

10.1.17 Merck

10.1.18 Nuvo Research

10.1.19 Regeneron Pharmaceuticals

10.1.20 Sanofi

10.1.21 SantoSolve

10.1.22 Techfields Pharma

10.1.23 Winston Pharmaceuticals

10.1.24 Yooyoung Pharmaceutical

10.1.25 Zynerba Pharmaceuticals

10.2 Osteoarthritis Pain Drugs Sales Date of Major Players (2017-2020e)

10.2.1 Abbott Laboratories

10.2.2 Johnson & Johnson

10.2.3 Novartis International

10.2.4 Pfizer

10.2.5 Abiogen Pharma

10.2.6 Afferent Pharmaceuticals

10.2.7 Astellas Pharma

10.2.8 BioDelivery Sciences International

10.2.9 Crystal Genomics

10.2.10 Cytori Therapeutics

10.2.11 Daiichi Sankyo

10.2.12 Eli Lilly

10.2.13 Endo Pharmaceuticals Holdings

10.2.14 Horizon Pharma

10.2.15 ICeutica

10.2.16 Iroko Pharmaceuticals

10.2.17 Merck

10.2.18 Nuvo Research

10.2.19 Regeneron Pharmaceuticals

10.2.20 Sanofi

10.2.21 SantoSolve

10.2.22 Techfields Pharma

10.2.23 Winston Pharmaceuticals

10.2.24 Yooyoung Pharmaceutical

10.2.25 Zynerba Pharmaceuticals

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

Table Osteoarthritis Pain Drugs Product Type Overview

Table Osteoarthritis Pain Drugs Product Type Market Share List

Table Osteoarthritis Pain Drugs Product Type of Major Players

Table Brief Introduction of Abbott Laboratories

Table Brief Introduction of Johnson & Johnson

Table Brief Introduction of Novartis International

Table Brief Introduction of Pfizer

Table Brief Introduction of Abiogen Pharma

Table Brief Introduction of Afferent Pharmaceuticals

Table Brief Introduction of Astellas Pharma

Table Brief Introduction of BioDelivery Sciences International

Table Brief Introduction of Crystal Genomics

Table Brief Introduction of Cytori Therapeutics

Table Brief Introduction of Daiichi Sankyo

Table Brief Introduction of Eli Lilly

Table Brief Introduction of Endo Pharmaceuticals Holdings

Table Brief Introduction of Horizon Pharma

Table Brief Introduction of ICeutica

Table Brief Introduction of Iroko Pharmaceuticals

Table Brief Introduction of Merck

Table Brief Introduction of Nuvo Research

Table Brief Introduction of Regeneron Pharmaceuticals

Table Brief Introduction of Sanofi

Table Brief Introduction of SantoSolve

Table Brief Introduction of Techfields Pharma

Table Brief Introduction of Winston Pharmaceuticals

Table Brief Introduction of Yooyoung Pharmaceutical

Table Brief Introduction of Zynerba Pharmaceuticals

Table Products & Services of Abbott Laboratories

Table Products & Services of Johnson & Johnson

Table Products & Services of Novartis International

Table Products & Services of Pfizer

Table Products & Services of Abiogen Pharma

Table Products & Services of Afferent Pharmaceuticals

Table Products & Services of Astellas Pharma

Table Products & Services of BioDelivery Sciences International

Table Products & Services of Crystal Genomics

Table Products & Services of Cytori Therapeutics

Table Products & Services of Daiichi Sankyo

Table Products & Services of Eli Lilly

Table Products & Services of Endo Pharmaceuticals Holdings

Table Products & Services of Horizon Pharma

Table Products & Services of ICeutica

Table Products & Services of Iroko Pharmaceuticals

Table Products & Services of Merck

Table Products & Services of Nuvo Research

Table Products & Services of Regeneron Pharmaceuticals

Table Products & Services of Sanofi

Table Products & Services of SantoSolve

Table Products & Services of Techfields Pharma

Table Products & Services of Winston Pharmaceuticals

Table Products & Services of Yooyoung Pharmaceutical

Table Products & Services of Zynerba Pharmaceuticals

Table Market Distribution of Major Players

Table Global Major Players Sales Revenue (Million USD) 2017-2020e

Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

Table Global Osteoarthritis Pain Drugs Market Forecast (Million USD) by Region 2021f-2026f

Table Global Osteoarthritis Pain Drugs Market Forecast (Million USD) Share by Region 2021f-2026f

Table Global Osteoarthritis Pain Drugs Market Forecast (Million USD) by Demand 2021f-2026f

Table Global Osteoarthritis Pain Drugs Market Forecast (Million USD) Share by Demand 2021f-2026f